Community post

The phage biotech company BiomX has presented in vivo data that shows successful intra-tumoural delivery of phages to Fusobacterium nucleatum, bacteria that reside inside tumours and whose presence is thought to protect tumours from chemotherapy. The phages were administered IV to a mouse model of colorectal cancer, and they saw that the delivered phages could successfully infect the intra-tumoral F. nucleatum.